Drawing for INVAREO

USPTO serial 79094050

INVAREO

Reviewed by CopyMark Law Group

Status 402
Filing date
Status date
Registration date
Examiner
SOUDERS, MICHAEL J
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with INVAREO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Bassam N. Ibrahim

Bassam N. Ibrahim Buchanan Ingersoll & Rooney, PCP.O. Box 1404Alexandria, VA 22313-1404UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations, namely, tablets, granules, pills, sachets, powders, and capsules, all for use in the treatment of mental and physical disorders, traumas and emergencies, addictions, aging, allergy/immunology, burns, diseases of the heart and blood vessels, dental and gum diseases, skin diseases, nutritional and dietary diseases, diseases of the endocrinological system and pancreatic diseases, diabetes, epidemical diseases, diseases and afflictions of the gastroenterological system, diseases of the blood, infectious diseases, neurological diseases, nephrological diseases, diseases in the obstetrical and gynecological field, cancer, ophthalmological diseases, diseases and afflictions affecting the bones, joints, cartilage material and muscles, diseases and afflictions of the ear, nose and throat, diseases and afflictions in the psychiatric field, pulmonological diseases and afflictions, rheumatism, urological diseases and afflictions and generalized pain"SECTION 70 - CANCELLED
040Treatment of materials, namely, milling, grinding, mixing, compressing and melting of pharmaceutical, medicinal, biotechnical and bacteriological substances, preparations, formulations, solutions for use in the pharmaceutical and medical industriesSECTION 70 - CANCELLED
041Educational training services, namely, arranging and conducting of seminars, workshops, conferences, lectures and congresses in the field of medicine, health and pharmaceuticalsSECTION 70 - CANCELLED
042Scientific research within the medical, pharmaceutical, biotechnical and bacteriological areas and providing consultation and information relating thereto; Product testing of pharmaceuticals for medical applications; packaging design for others; designing and development of medical equipment; development of pharmaceutical and medical preparations; development of pharmaceutical formulations; design and development of granulation technology and tablet technology and providing consulting and information theretoSECTION 70 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 15, 2016NREPNEW REPRESENTATIVE AT IB RECEIVED
Mar 30, 2012DETHDEATH OF INTERNATIONAL REGISTRATION
Mar 12, 2012ETOFEXTENSION OF TIME TO OPPOSE RECEIVED
Feb 14, 2012NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 14, 2012PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 26, 2012ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Jan 25, 2012NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 10, 2012PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 9, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jan 9, 2012TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jan 9, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 9, 2012TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 19, 2011CEPECOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
Oct 19, 2011GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Oct 19, 2011GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Oct 19, 2011CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Sep 30, 2011TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Sep 30, 2011CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 21, 2011ALIEASSIGNED TO LIE
Sep 19, 2011TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 17, 2011RFNTREFUSAL PROCESSED BY IB
Mar 24, 2011RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 24, 2011RFRRREFUSAL PROCESSED BY MPU
Mar 24, 2011RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 23, 2011CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 23, 2011DOCKASSIGNED TO EXAMINER
Mar 22, 2011MAFRAPPLICATION FILING RECEIPT MAILED
Mar 18, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 17, 2011REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance